Carlo Gambacorti-Passerini
Carlo Gambacorti-Passerini
Carlo Gambacorti-Passerini (pronunciation: /ˈkɑːrloʊ ˌɡæmbəˈkɔːrti pæsəˈrini/) is an Italian oncologist and researcher known for his significant contributions to the field of cancer research, particularly in the study of chronic myeloid leukemia (CML).
Etymology
The name Carlo is of Italian origin, derived from the Germanic name Karl, meaning "free man". Gambacorti is a surname of Italian origin, while Passerini is a patronymic surname derived from the given name Passero, meaning "sparrow" in Italian.
Career
Carlo Gambacorti-Passerini is a professor of hematology at the University of Milano Bicocca in Milan, Italy. He is also the director of the Department of Oncology and Hemato-Oncology at the same university. His research primarily focuses on the molecular mechanisms of tyrosine kinase inhibitors (TKIs) in the treatment of chronic myeloid leukemia.
Contributions
Gambacorti-Passerini has made significant contributions to the understanding of the molecular mechanisms of tyrosine kinase inhibitors and their role in the treatment of chronic myeloid leukemia. His research has led to the development of new therapeutic strategies for patients with this type of cancer.
Related Terms
- Oncology: The study and treatment of tumors.
- Hematology: The study of blood, blood-forming organs, and blood diseases.
- Chronic myeloid leukemia: A type of cancer that starts in certain blood-forming cells of the bone marrow.
- Tyrosine kinase inhibitors: A type of drug that blocks signals needed for tumors to grow.
External links
- Medical encyclopedia article on Carlo Gambacorti-Passerini
- Wikipedia's article - Carlo Gambacorti-Passerini
This WikiMD article is a stub. You can help make it a full article.
Languages: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
Urdu,
বাংলা,
తెలుగు,
தமிழ்,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
European
español,
Deutsch,
français,
русский,
português do Brasil,
Italian,
polski